Back to Rankings

ECVT

EcovystB
NYSE / Materials
Last Price
At close
2026-06-02
View Chart

AI scenario view

RankAlpha Sentiment CodexPost-earnings T+3
B+
Bull case
25%
Probability
Target price
$16.50
+24.4% vs current
Most likely
B
Base case
50%
Probability
Target price
$14.50
+9.4% vs current
B-
Bear case
25%
Probability
Target price
$11.50
-13.3% vs current

AI sentiment snapshot

Latest data as of 2026-05-08
Recent news sentiment (30D)
+20.1
Positive
Company
-
Unavailable
Macro
+20.1
Positive
Pulse
+16.6
Positive
Sentiment proxy
+56.4
Score

AI commentary

This is still more of a cautious post-earnings monitoring setup than a strong rerating thesis. Company-source evidence improved materially on May 5, 2026, and third-party coverage framed the print as an earnings beat with higher full-year outlook, while StockAnalysis shows at least one target increase on May 6, 2026. But the market reaction appears mixed by T+3: external coverage indicated a positive immediate reaction, yet ECVT closed at $13.97 on May 7, 2026 versus a cited May 4, 2026 close of $14.12, suggesting the initial upside was not fully retained. Social coverage was not provided in the packet, so confidence rests mainly on the filing and IR release rather than broad sentiment follow-through.

RankAlpha Sentiment Codex - 2026-05-08
Open post-earnings memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-05-05eventQ1 beat with higher 2026 sales and cash-flow outlookHigh impact

Ecovyst reported Q1 2026 continuing-operations sales of $215.0 million, up 50% year over year, and adjusted EBITDA of $39.8 million, up 87%, then raised 2026 sales guidance to $890-$970 million from $860-$940 million and adjusted free cash flow guidance to $40-$55 million from $35-$55 million [#8-K-2026-05-05] [#10-Q-2026-05-05].

2026-09-30catalystOngoing buyback support after heavy Q1 repurchasesMedium impact

Ecovyst repurchased 3.23 million shares in Q1 2026 for $35.7 million at an average price of $11.07 and still had $146.5 million remaining under the authorization as of March 31, 2026, supporting near-term capital-allocation optionality [#8-K-2026-05-05].

2026-12-31catalystRegeneration and virgin sulfuric acid demand plus Waggaman contributionHigh impact

Management said regeneration services growth was driven by high refinery utilization, favorable alkylate economics, lower customer downtime, and favorable pricing, while virgin sulfuric acid volumes rose more than 30% with help from Waggaman; the company also plans about $20 million of 2026 investment in two projects for the growing virgin sulfuric acid customer base [#8-K-2026-05-05].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-05-08 • Updated nightlySource: Internal modelMethodology